From June 11 to 13, the Rimini Palacongressi in Italy will host the 64th AFI Symposium: a complete overview of the scheduled sessions, with a special focus on educational materials in pharmacovigilance.

The annual AFI Symposium returns this year for its 64th edition. From June 11 to 13, 2025, the Rimini Palacongressi will once again welcome pharmaceutical professionals, companies, regulatory authorities, and service providers for three days of updates, dialogue, and networking.
For over sixty years, the event has been a key opportunity to follow the regulatory, scientific, and technological developments that shape the pharmaceutical value chain.

What is the AFI Symposium?

The AFI Symposium, organized by the Associazione Farmaceutici Industria, is one of the most important scientific and industrial events in the Italian pharmaceutical landscape.
For more than six decades, it has brought together over a thousand participants and offers a rich program of scientific sessions and workshops, alongside a large exhibition area where companies and professionals showcase cutting-edge solutions and technologies.
This year’s edition will take place from June 11 to 13, 2025, again at the Rimini Palacongressi. The central theme is: From knowledge to digitalization for a competitive healthcare industry.

AFI Symposium 2025: the program

The Symposium agenda includes 18 scientific sessions over three days. The topics range from sustainability to digitalization, medical devices to clinical research, with a strong focus on regulatory affairs and pharmacovigilance.

Wednesday, June 11 – 3:15 PM to 6:45 PM

  • Session I – Energy and Sustainability
  • Session II – Innovation (Industry 5.0)
  • Session III – Clinical Research

Thursday, June 12

  • 9:00–11:00 AM – Session IV: HTA
  • 11:30 AM–1:30 PM – Session V: Regulatory Affairs
  • 9:00 AM–1:00 PM – Session VI: Quality
  • 9:00 AM–1:00 PM – Session VII: Biotech
  • 9:00–11:00 AM – Session VIII: Special Productions
  • 11:30 AM–1:30 PM – Session IX: PVV – Value Based Healthcare
  • 3:15–6:45 PM – Session X: Medical Devices
  • 3:15–6:45 PM – Session XI: Supply Chain
  • 2:30–4:30 PM – Session XII: Pharmacovigilance
  • 3:15–5:15 PM – Session XIII: Pharmaceutical Sciences
  • 5:45–7:45 PM – Session XIV: CRS-SITELF

Friday, June 13

  • 9:00 AM–1:00 PM – Session XV: Manufacturing
  • 9:00 AM–1:00 PM – Session XVI: Digital Health
  • 9:30–11:00 AM – Session XVII: Raw Materials
  • 9:30 AM–1:00 PM – Session XVIII: Social Trends in the Pharmaceutical Supply Chain

The full and updated program is available on the official website: www.simposioafi.it

Spotlight on the Pharmacovigilance session

One of the most anticipated moments of the second day is Session XII – Pharmacovigilance, titled:
“Educational Materials: Managing Effectively in the Digital Age.”

Scheduled for Thursday, June 12, from 2:30 to 4:30 PM, in Sala del Castello 2, the session will focus on the evolution of additional risk minimisation measures (aRMMs), following the update of GVP Module XVI and the ongoing transformation in risk communication methods and channels.

An AFI working group on pharmacovigilance has developed a project analysing the Italian landscape and proposing ways to improve the effectiveness of educational materials targeting both healthcare professionals (prescribers and dispensers) and patients.

Speakers will include representatives from AIFA, patient associations, healthcare professional organizations, and industry experts, with contributions from Farmindustria and Egualia.
The session will conclude with an open roundtable discussion, allowing attendees to ask questions and interact directly with the panel.

SafetyDrugs among the exhibitors

Once again, SafetyDrugs will be among the official exhibitors at the AFI Symposium. You can find us at stand 145, ready to welcome those interested in learning more about SafetyDrugs, our pharmacovigilance database, and its integrated Business Intelligence module.

We look forward to meeting professionals and colleagues to share insights, strengthen collaborations, and stay aligned with the latest developments in drug safety.

Want to revisit last year’s edition? Read more here:
AFI Symposium 2024: scientific sessions and pharma networking
AFI Symposium 2024: the latest from the pharmaceutical industry